Skip to content
HowShorted

ABEONA THERAPEUTICS INC. short interest in 2019

In 2019, ABEONA THERAPEUTICS INC.'s disclosed short interest ran from 0.00% of shares outstanding on 15 Jan 2019 to 7.97% on 31 Dec 2019, a change of +7.97 percentage points. The year's high was 9.42% on 15 Nov 2019 and its low 0.00% on 15 Jan 2019, averaging 1.69% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 41.67 days on 15 Apr 2019. Full history: ABEONA THERAPEUTICS INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ABEONA THERAPEUTICS INC. in 2019

2019 in figures

Start of year
0.00% (15 Jan 2019)
End of year
7.97% (31 Dec 2019)
Change
+7.97 pp
High
9.42% (15 Nov 2019)
Low
0.00% (15 Jan 2019)
Average
1.69%
Highest days to cover
41.67 (15 Apr 2019)
SEC filings marked
8

Every report in 2019

ABEONA THERAPEUTICS INC. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 20190.00%1.00
31 Jan 20190.00%7.26
15 Feb 20190.00%5.55
15 Mar 20190.00%22.73
29 Mar 20190.00%1.0010-K filed, results (8-K)
15 Apr 20190.00%41.67
30 Apr 20190.00%1.35
15 May 20190.00%1.4510-Q filed, results (8-K)
31 May 20190.00%1.00
28 Jun 20190.00%1.00
15 Jul 20190.00%1.00
31 Jul 20190.00%1.00
15 Aug 20190.00%1.5910-Q filed, results (8-K)
30 Aug 20190.01%3.09
13 Sep 20190.01%1.00
30 Sep 20190.01%3.83
15 Nov 20199.42%20.5510-Q filed, results (8-K)
29 Nov 20198.45%8.12
13 Dec 20197.93%2.46
31 Dec 20197.97%1.51

See also: ABEONA THERAPEUTICS INC.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.